drugset / Trial / NCT07358234
Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.
Phase 0
Enrolling by invitation
60 enrolled
Mayo Clinic
Vanderbilt University Medical Center · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare Eosinophilic Esophagitis treatments Eohilia with Dupixent in their effects on diameter and scarring of the esophagus.
Timeline
- Start
- 2026-02-04
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 2 mg | Oral |
| Comparator | Dupilumab | Monoclonal antibody | 300 mg | Subcutaneous |